Compare FMC Corp (FMC) vs Strategy Inc. (MSTR) Price & Performance

FMC Corporation (FMC) trades at $11.61, up 8.3% today, but remains in a challenging fundamental position with a net income margin of -72.93% and negative ROE of -80.78% for 2025. The company is actively restructuring, securing a $400 million minority investment from Tessenderlo Group and planning a $114 million property sale to reduce its $3.03 billion long-term debt. Technical indicators are bearish, with the stock trading near key support at $11. Recent news highlights progress on its new herbicide, rimisoxafen, including a regulatory submission to the EPA and a partnership with Corteva.

The outlook is cautious. While aggressive debt reduction and new product pipelines offer potential, deep losses and declining revenue pose significant risks. The analyst consensus is mixed (47.6% Buy, 50% Hold) with a $16 price target, suggesting modest upside if turnaround efforts succeed, but high execution risk remains the primary concern for investors.

MSTR trades at $94.10, down 3.57% on the day, with technical indicators showing a neutral to bearish near-term bias. The company reported Q1 2026 EPS of -$38.25, missing expectations, and maintains a negative net income margin of -2,482.01%. Recent news highlights the company's strategic shift in Bitcoin holdings and liquidity management, with CEO Phong Le emphasizing long-term Bitcoin acquisition despite recent sales to meet obligations (Bloomberg, 2026-07-15).

The outlook remains challenged by persistent losses and high volatility linked to Bitcoin's price, though analyst consensus is bullish with a $237.63 price target. Key risks include funding pressures from negative cash flow and dependence on Bitcoin's performance. Investment opportunity hinges on a potential Bitcoin rally reversing recent underperformance.